Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parametersSatoru Watanabe, Seigo Kinuya, Shohei Yoshida et al.|Journal of Nuclear Cardiology|2021Cited by 19
Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hoursSatoru Watanabe, Seigo Kinuya, Kenichi Nakajima et al.|Journal of Nuclear Cardiology|2023Cited by 8